Moxie Dwight 4
4 · Revance Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Moxie Dwight
CLO & GC
Transactions
- Tax Payment
Common Stock
2023-03-15$30.65/sh−7,330$224,665→ 48,217 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock awards (the"RSA") totaling 14,783 shares. 8,334 of the shares were issued pursuant to a RSA vested in three equal annual installments from March 15, 2020, and the remaining 6,449 shares were issued pursuant to a RSA that vests in three equal annual installments from March 15, 2021.